|

Claudin 18.2 CAR-T Clinical Trials

1 actively recruiting trial

Also known as: IMC002

Pipeline

Phase 1: 1

Top Sponsors

  • Suzhou Immunofoco Biotechnology Co., Ltd1

Indications

  • Advanced Ovarian Carcinoma1
  • Gastroesophageal Junction Adenocarcinoma1
  • Pancreatic Cancer1
  • Gastric Cancer1
  • Cancer1

Other1 trial

Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.